FDA Approved: ZIRGAN — Supplemental Application (Bausch & Lomb Incorporated)

View source ↗

Summary

FDA Approved: Zirgan (ganciclovir) by Bausch & Lomb received a supplemental application approval, updating the labeling for the ophthalmic gel.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Herpetic Keratitis

Drugs mentioned

• ZIRGAN (GANCICLOVIR)

Snippet

SUPPL AP for ZIRGAN (GANCICLOVIR)